{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:01:51Z","timestamp":1789891311696,"version":"4.0.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034808","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T21:06:48Z","timestamp":1334783208000},"page":"e34808","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of the G375C and G346E Achondroplasia Mutations on FGFR3 Activation"],"prefix":"10.1371","volume":"7","author":[{"given":"Lijuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish","family":"Niphadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Shobnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalina","family":"Hristova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling.","volume":"411","author":"P Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2174\/1381612023393530","article-title":"Receptor tyrosine kinases as target for anti-cancer therapy.","volume":"8","author":"S Brunelleschi","year":"2002","journal-title":"Current Pharmaceutical Design"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.cb.10.110194.001343","article-title":"Receptor protein-tyrosine kinases and their signal transduction pathways.","volume":"10","author":"P van der Geer","year":"1994","journal-title":"Annu Rev Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/156800909788166484","article-title":"HER-2 Signaling and Inhibition in Breast Cancer.","volume":"9","author":"BC Browne","year":"2009","journal-title":"Current Cancer Drug Targets"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ceb.2007.02.010","article-title":"Receptor tyrosine kinases: mechanisms of activation and signaling.","volume":"19","author":"SR Hubbard","year":"2007","journal-title":"Cur Opinion Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases.","volume":"103","author":"J Schlessinger","year":"2000","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/MCB.16.3.977","article-title":"Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction.","volume":"16","author":"M Mohammadi","year":"1996","journal-title":"Mol Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.bi.62.070193.002321","article-title":"Signaling by Receptor Tyrosine Kinases.","volume":"62","author":"WJ Fantl","year":"1993","journal-title":"Annu Rev Biochem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","article-title":"Structural basis for FGF receptor dimerization and activation.","volume":"98","author":"AN Plotnikov","year":"1999","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00774-008-0009-7","article-title":"FGFR3-related dwarfism and cell signaling.","volume":"27","author":"D Harada","year":"2009","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"ref11","first-page":"23","article-title":"The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.","volume":"21","author":"Z Vajo","year":"2000","journal-title":"Endocrine Reviews"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0168-9525(97)01131-1","article-title":"FGFR activation in skeletal disorders: Too much of a good thing.","volume":"13","author":"MK Webster","year":"1997","journal-title":"Trends Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0168-9525(00)02021-7","article-title":"RTK mutations and human syndromes - when good receptors turn bad.","volume":"16","author":"SC Robertson","year":"2000","journal-title":"Trends Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.onc.1209957","article-title":"EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer.","volume":"26","author":"SH Choi","year":"2007","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/ddh011","article-title":"Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity.","volume":"13","author":"OA Ibrahimi","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1021\/bi060609y","article-title":"Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.","volume":"45","author":"E Li","year":"2006","journal-title":"Biochemistry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jmb.2008.10.036","article-title":"Pathogenic activation of receptor tyrosine kinases in mammalian membranes.","volume":"384","author":"L He","year":"2008","journal-title":"J Mol Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1529\/biophysj.106.092247","article-title":"Neutron diffraction studies of fluid bilayers with transmembrane proteins: Structural consequences of the achondroplasia mutation.","volume":"91","author":"X Han","year":"2006","journal-title":"Biophys J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.2002.17.5.860","article-title":"Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.","volume":"17","author":"R Adar","year":"2002","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1038\/sj.onc.1206587","article-title":"Signal transduction by several KIT juxtamembrane domain mutations.","volume":"22","author":"N Casteran","year":"2003","journal-title":"Oncogene"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/339230a0","article-title":"A Point Mutation in the Neu Oncogene Mimics Ligand Induction of Receptor Aggregation.","volume":"339","author":"DB Weiner","year":"1989","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations.","volume":"14","author":"MR Passos-Bueno","year":"1999","journal-title":"Human Mutation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.","volume":"13","author":"MC Naski","year":"1996","journal-title":"Nat Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/ajmg.a.31368","article-title":"The new bone biology: Pathologic, molecular, and clinical correlates.","volume":"140A","author":"MM Cohen","year":"2006","journal-title":"American Journal of Medical Genetics Part A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ajmg.10780","article-title":"Some chondrodysplasias with short limbs: Molecular perspectives.","volume":"112","author":"MM Cohen","year":"2002","journal-title":"American Journal of Medical Genetics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s002470050165","article-title":"Short-limb skeletal dysplasias and craniosynostosis: What do they have in common?","volume":"27","author":"MM Cohen","year":"1997","journal-title":"Pediatric Radiology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0901-5027(98)80036-2","article-title":"Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level.","volume":"27","author":"MM Cohen","year":"1998","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ajmg.a.31084","article-title":"Severe complications in a child with achondroplasia and two FGFR3 mutations on the same allele.","volume":"140A","author":"P Rump","year":"2006","journal-title":"American Journal of Medical Genetics Part A"},{"key":"ref29","first-page":"748","article-title":"Mutations in Fibroblast Growth-Factor Receptors - Phenotypic Consequences During Eukaryotic Development.","volume":"57","author":"WJ Park","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"ref30","first-page":"151A","article-title":"A novel G346E FGFR3 mutation in achondroplasia.","volume":"37","author":"P Prinos","year":"1995","journal-title":"Pediatr Res Suppl"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.bbamem.2011.04.007","article-title":"The A391E mutation enhances FGFR3 activation in the absence of ligand.","volume":"1808","author":"F Chen","year":"2011","journal-title":"Biochimica et Biophysica Acta-Biomembranes"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1021\/bi200986f","article-title":"The Physical Basis of FGFR3 Response to fgf1 and fgf2.","volume":"50","author":"FH Chen","year":"2011","journal-title":"Biochemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1074\/jbc.M110.205583","article-title":"FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism.","volume":"286","author":"L He","year":"2011","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbamem.2010.08.007","article-title":"Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.","volume":"1808","author":"LJ He","year":"2011","journal-title":"Biochimica et Biophysica Acta-Biomembranes"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"30103","DOI":"10.1074\/jbc.M109.094086","article-title":"The physical basis behind achondroplasia, the most common form of human dwarfism.","volume":"285","author":"L He","year":"2010","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2106\/00004623-197052040-00004","article-title":"Skeletal Growth in Achondroplasia.","volume":"52","author":"IV Ponseti","year":"1970","journal-title":"Journal of Bone and Joint Surgery-American Volume A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia.","volume":"370","author":"WA Horton","year":"2007","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.","volume":"78","author":"R Shiang","year":"1994","journal-title":"Cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.","volume":"15","author":"MK Webster","year":"1996","journal-title":"EMBO J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jmb.2005.11.077","article-title":"FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.","volume":"356","author":"E Li","year":"2006","journal-title":"J Mol Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1021\/bi700986n","article-title":"Effect of pathogenic cysteine mutations on FGFR3 transmembrane domain dimerization in detergents and lipid bilayers.","volume":"46","author":"M You","year":"2007","journal-title":"Biochemistry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.","volume":"101","author":"JY Cho","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(02)03255-6","article-title":"FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation.","volume":"528","author":"E Monsonego-Ornan","year":"2002","journal-title":"FEBS Lett"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/j.1742-4658.2007.05835.x","article-title":"The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor.","volume":"274","author":"J Bonaventure","year":"2007","journal-title":"Febs Journal"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","article-title":"The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation.","volume":"20","author":"E Monsonego-Ornan","year":"2000","journal-title":"Mol Cell Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FCFR3 Lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.","volume":"67","author":"GA Bellus","year":"2000","journal-title":"American Journal of Human Genetics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng1295-462","article-title":"Fibroblast-Growth-Factor-Receptor-3 (Fgfr3) Transmembrane Mutation in Crouzon-Syndrome with Acanthosis Nigricans.","volume":"11","author":"GA Meyers","year":"1995","journal-title":"Nat Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T13:19:02Z","timestamp":1561641542000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034808"}},"subtitle":[],"editor":[{"given":"Reiner Albert","family":"Veitia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034808","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}